Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02678949Unknown
Open-label trial of fluticasone propionate nasal spray in asthma (3 arms), sponsored by Hospital Infantil de México Federico Gómez. Primary endpoint: Effect of bronchodilator on the Lung Clearance Index. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02678949.